A surgical gas delivery system is disclosed for gas sealed insufflation and recirculation during an endoscopic or laparoscopic surgical procedure, which includes a gaseous sealing manifold for communicating with a gas sealed access port, a compressor for recirculating gas through the gaseous sealing manifold, and a source of UVC irradiation for sterilizing at least the gas recirculating through the gaseous sealing manifold.

A surgical gas delivery system is disclosed for gas sealed insufflation and recirculation, which includes a gaseous sealing manifold for communicating with a gas sealed access port, an insufflation manifold for communicating with the gas sealed access port and with a valve sealed access port, a compressor for recirculating gas through the gas sealed access port by way of the gaseous sealing manifold, a first outlet line valve associated with the insufflation manifold for controlling a flow of insufflation gas to the gas sealed access port, a second outlet line valve associated with the insufflation manifold for controlling a flow of insufflation gas to the valve sealed access port, and a proportional valve associated the insufflation manifold and located upstream from the first and second outlet line valves for dynamically controlling the flow of insufflation gas to the first and second outlet line valves.

The present invention describes a method for performing a prostate surgical treatment, said method comprising: arranging a catheter 1 inside of a urethra of a patient and anchored against the bladder neck of the patient subsequent to the filling of the balloon stopper unit 5 with a fluid when the balloon stopper unit 5 is arranged inside of the bladder of a patient;
said method also comprising injecting at least one anesthetic agent and adrenaline or injecting botulinum toxin (Botox) and/or penicillin to the prostate via the injection tube 9 and the hollow tip 10 at an intended position of the prostate.

Moreover, the present invention also refers to a kit comprising a catheter 1 according to the present invention and one or more syringe(s) 1000 containing adrenaline and at least one anesthetic agent and/or at least a syringe 1000 or vial containing botulinum toxin (Botox) and/or penicillin.

A breathing treatment apparatus delivers breathing gas to a user. The apparatus may be configured to comprise one or more sensors for sensing microbial growth within the apparatus.

The improvement device provides an oral suction system for use with endo-tracheal tubes. The device provides alternative anti-infective components and a removable and/or disposable external sleeve, both for mitigation or elimination of risks for viral and/or bacterial contamination of the patient and healthcare professional.

The present invention provides methods and systems for conditioning cerebrospinal fluid (CSF) by removing target compounds from CSF. The systems provide for a catheter flow path and exchange of a majority volume portion of CSF in the CSF space. The removal and/or delivery of specific compounds can be tailored to the pathology of the specific disease. The removal is targeted and specific, for example, through the use of specific size-exclusion thresholds, antibodies against specific toxins, and other chromatographic techniques, as well as delivery and/or removal of targeted therapeutic agents.

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.

A respiratory filter and condensate management apparatus is provided for use in a breathing circuit during patient respiration. The apparatus includes a housing having an air inlet port for receiving a flow of respiratory air, and an air outlet port for outputting the flow of respiratory air to a ventilator. A filter compartment is provided within the housing and includes a filter member located in a flow path of the respiratory air from the air inlet port to the air outlet port. A condensate collection compartment is provided within the housing and includes at least one reservoir and at least one self-sealing drainage port. The reservoir collects liquid formed by condensation of the respiratory air within the filter compartment, and the drainage port allows removal of the collected liquid from the reservoir while the housing remains connected to the breathing circuit.

A respiratory filter and condensate management apparatus is provided for use in a breathing circuit during patient respiration. The apparatus includes a housing having an air inlet port for receiving a flow of respiratory air, and an air outlet port for outputting the flow of respiratory air to a ventilator. A filter compartment is provided within the housing and includes a filter member located in a flow path of the respiratory air from the air inlet port to the air outlet port. A condensate collection compartment is provided within the housing and includes at least one reservoir and at least one self-sealing drainage port. The reservoir collects liquid formed by condensation of the respiratory air within the filter compartment, and the drainage port allows removal of the collected liquid from the reservoir while the housing remains connected to the breathing circuit.